FDA Approves Breakthrough Cell Therapy for Metastatic Melanoma
TL;DR Summary
The FDA has approved a groundbreaking cancer therapy that uses a patient's own cells to treat advanced melanoma, marking a significant milestone in cancer treatment. The therapy, developed by Iovance Biotherapeutics, involves extracting tumor-infiltrating lymphocytes from the patient, multiplying them in a lab, and then infusing them back into the body to supercharge the immune system's ability to fight cancer. This approval signals a new era in cancer treatment and offers hope for patients with limited treatment options.
Topics:business#cancer-therapy#fda-approval#health-medicine#immunotherapy#iovance-biotherapeutics#tumor-infiltrating-lymphocytes
- New cancer therapy approved by FDA supercharges body’s immune system The Washington Post
- Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi Yahoo Finance
- In 'major milestone,' FDA approves first cell therapy for solid tumors STAT
- US FDA grants accelerated approval for Iovance's skin cancer cell therapy Reuters
- FDA approves new therapy for hard-to-treat metastatic melanoma CNN
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
90%
748 → 78 words
Want the full story? Read the original article
Read on The Washington Post